Mabloc, LLC
Immunity for Humanity
MIAMI, United States · Founded 2020 · $3.3M raised
- Headquarters
- MIAMI, Florida
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- mabloc.com
- Total Funding
- $3.3M
- Last Round
- $3.3M GrantAug 2021
- Rounds
- 1
About
Mabloc is an AI-driven biotechnology company developing monoclonal antibodies for infectious diseases including yellow fever, dengue, Zika, and COVID-19. Its proprietary BRAID™ platform uses AI to analyze biological data and design antibodies with speed and precision, accelerating the path from discovery to patient treatment.
Summary
Mabloc, LLC is an Artificial Intelligence company based in MIAMI, United States, founded in 2020. It has raised $3.3M in total across 1 round, most recently a $3.3M Grant round in Aug 2021. Investors include HHS.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2021
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company